Thermo Fisher Scientific Inc.
TMO
$492.60
$3.110.64%
NYSE
| 06/28/2025 | 03/29/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.73% | -9.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.74% | -9.05% | |||
| Cost of Revenue | 5.28% | -6.61% | |||
| Gross Profit | 3.96% | -12.35% | |||
| SG&A Expenses | 2.96% | -5.28% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.62% | -6.68% | |||
| Operating Income | 5.27% | -18.62% | |||
| Income Before Tax | 6.54% | -18.64% | |||
| Income Tax Expenses | -3.16% | -36.67% | |||
| Earnings from Continuing Operations | 7.15% | -17.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 50.00% | -166.67% | |||
| Net Income | 7.30% | -17.65% | |||
| EBIT | 5.27% | -18.62% | |||
| EBITDA | 3.06% | -15.39% | |||
| EPS Basic | 7.30% | -16.78% | |||
| Normalized Basic EPS | 5.59% | -21.37% | |||
| EPS Diluted | 7.48% | -16.74% | |||
| Normalized Diluted EPS | 5.86% | -21.37% | |||
| Average Basic Shares Outstanding | 0.00% | -1.05% | |||
| Average Diluted Shares Outstanding | -0.26% | -1.04% | |||
| Dividend Per Share | 0.00% | 10.26% | |||
| Payout Ratio | 0.01% | 0.21% | |||